IVZ Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Invesco Ltd (IVZ) is not a strong buy at the moment for a beginner, long-term investor. While there are some positive catalysts such as recent product launches and partnerships, the company's financial performance in the latest quarter shows significant challenges, including a substantial net income loss and negative EPS. Additionally, hedge fund selling and lack of strong trading signals suggest caution. The stock may be better suited for monitoring rather than immediate investment.
The MACD is positive and expanding, indicating a potential upward trend. RSI is neutral at 60.058, and moving averages are converging, suggesting no strong directional momentum. The stock is trading near its first resistance level (R1: 27.092), which could act as a short-term ceiling.
Invesco's launch of new bond ETFs and fixed-income products to address interest rate volatility.
Partnership with Bozzuto Group for a $1 billion investment in multifamily assets.
Healthy net long-term inflows of $19.1 billion over 10 consecutive quarters.
Hedge funds are aggressively selling, with a 14710.43% increase in selling activity last quarter.
Significant net income loss of -$1.19 billion in Q4 2025, with EPS dropping to -2.
Analysts have mixed ratings, with some lowering price targets due to higher costs and reduced EPS estimates.
In Q4 2025, revenue increased by 6.24% YoY to $1.13 billion. However, net income dropped drastically to -$1.19 billion (-666.75% YoY), and EPS fell to -2.63 (-671.74% YoY). Gross margin remained flat at 0%.
Analysts are mixed on IVZ. Some firms, like TD Cowen and Argus, raised price targets and maintain Buy ratings due to better-than-expected Q4 results and margin expansion. Others, like BofA and Morgan Stanley, lowered price targets and EPS estimates due to higher costs and distribution fees.
